Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|April 3, 2013
AntithrombinMirta Hepner, Vasiliki KarlaftisBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 21, 2015
Importance of post-translational modifications on the function of key haemostatic proteinsVasiliki Karlaftis, Sachin Perera, Paul Monagle, et al.Clinical Chemistry and Laboratory Medicine|July 5, 2022
Age partitioned and continuous upper reference limits for Ortho VITROS High Sensitivity Troponin I in a healthy paediatric cohortJoel Smith, Vasiliki Karlaftis, Stephen Hearps, et al.Thrombosis Research|December 17, 2025
The in vitro anticoagulant effect of milvexian in healthy neonates and childrenNatasha Letunica, Vasiliki Karlaftis, Paul Monagle, et al.Clinical Chemistry and Laboratory Medicine|March 12, 2021
Continuous reference intervals for leukocyte telomere length in children: the method mattersAnalia Lesmana, Pei Tian, Vasiliki Karlaftis, et al.Pediatric Nephrology (Berlin, Germany)|May 25, 2020
Reference intervals for serum cystatin C in neonates and children 30 days to 18 years oldTengyi Cai, Vasiliki Karlaftis, Stephen Hearps, et al.Journal of Proteomics|April 15, 2015
Differences in the resting platelet proteome and platelet releasate between healthy children and adultsCharmaine Cini, Christina Yip, Chantal Attard, et al.Research and Practice in Thrombosis and Haemostasis|April 23, 2026
The <i>in vitro</i> anticoagulant effect of abelacimab in healthy childrenNatasha Letunica, Simon Collett, Vasiliki Karlaftis, et al.Pageof 4